LACTOVID

Serial Number 97291309
733

Registration Progress

Application Filed
Mar 2, 2022
Under Examination
Mar 14, 2023
Approved for Publication
Jan 17, 2023
Published for Opposition
Jan 17, 2023
Registered

Attorney Assistance

Statement of Use Due - Extension 4 Granted
Due: Sep 14, 2025 55 days

Trademark Image

LACTOVID

Basic Information

Serial Number
97291309
Filing Date
March 2, 2022
Published for Opposition
January 17, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
733
Status Date
Feb 18, 2025
Application
Pending
Classes
005

Rights Holder

University of Florida Research Foundation, Incorporated

03
Address
223 Grinter Hall, #115500
Gainesville, FL 32611

Ownership History

University of Florida Research Foundation, Incorporated

Original Applicant
03
Gainesville, FL

University of Florida Research Foundation, Incorporated

Owner at Publication
03
Gainesville, FL

Legal Representation

Attorney
Mary Grace Gallagher

USPTO Deadlines

Next Deadline
55 days remaining
Statement of Use Due - Extension 4 Granted
Due Date
September 14, 2025
Extension Available
Until March 14, 2024

Application History

28 events
Date Code Type Description Documents
Feb 19, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 18, 2025 EX4G S SOU EXTENSION 4 GRANTED Loading...
Feb 18, 2025 EXT4 S SOU EXTENSION 4 FILED Loading...
Feb 18, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 30, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Aug 30, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Aug 30, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 30, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 23, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 22, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Feb 22, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Feb 22, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 7, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 5, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Sep 5, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Sep 5, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 14, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 17, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 17, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 28, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 13, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 12, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Dec 12, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Dec 12, 2022 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Dec 12, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Nov 30, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 7, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 5, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Antiviral pharmaceutical preparations comprised of diphenhydramine and lactoferrin for the treatment and prevention of Covid-19

Classification

International Classes
005